WHO Recommends Lowering HPV Vaccination Starting Age
The WHO now suggests countries consider HPV shots for girls as young as 4 to help boost low global vaccination rates.
Updated on Oct. 25, 2026 in Cancer

Live Poll
Do you support expanding routine HPV vaccination programs to children as young as four?
The World Health Organisation's SAGE group now recommends that countries consider expanding routine HPV vaccination to girls as young as 4 years old. This adjustment aims to boost global vaccine uptake, which currently sits well below the international 90 per cent target.
Why it matters
Expanding the vaccination age range is a strategic effort to close the gap between current coverage and the 90 per cent target needed to curb the rising burden of cervical cancer. By reaching younger children, health officials aim to improve long-term prevention against the virus.
Official public health policy data shows current global HPV vaccine coverage is at 33 per cent, falling far short of the 90 per cent goal. While 165 countries have already introduced the vaccine, the effectiveness of lowering the vaccination age to 4 remains under investigation.
The players
World Health Organisation
The United Nations agency responsible for international public health and setting global immunization standards.
Strategic Advisory Group of Experts on Immunisation (SAGE)
The principal advisory group to the World Health Organisation for vaccines and immunization policies.
The details
The strategy involves widening the eligibility for the single-dose HPV vaccination schedule to include children aged 4 to 8. Eight HPV vaccines are currently licensed globally to prevent infections that can lead to cervical cancer, which caused 604,000 new cases and 280,000 deaths in 2024. By capturing a younger cohort, the initiative intends to simplify routine immunization schedules and increase total population immunity.
Timeline
2022: SAGE recommended a one- or two-dose HPV schedule.
2024: 604,000 new cervical cancer cases and 280,000 deaths occurred.
End of 2025: Over 95 million girls received HPV vaccines.
Health Landscape
This move marks a shift in the global strategy to accelerate the elimination of cervical cancer by broadening the window for early childhood intervention. It follows a multi-year effort to refine dose schedules while navigating complex vaccine access challenges across different regions.
Parents and guardians should speak with their pediatrician about current local vaccination schedules, as policies may vary by country. This development highlights the importance of staying informed about immunization milestones that are designed to protect against preventable cancer risks.
The takeaway
Expanding HPV vaccination to younger age groups is a critical step in reaching global cervical cancer prevention targets. Readers are encouraged to discuss the appropriate timing for all recommended childhood immunizations with their primary healthcare provider.
Further reading
For more on preventative measures and current clinical guidelines, explore our Cancer section.
Source note: This article includes information reported by NST Online.
Live Poll
Do you support expanding routine HPV vaccination programs to children as young as four?






